NVDA
NVIDIA Corporation
NVDA has the edge over PRCH overall, supported by stronger valuation and stronger fundamentals.
PRCH
Porch Group, Inc.
PRCH's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PRCH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
PRCH's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PRCH PE Valuation
PRCH has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 64x next year's earnings.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PRCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
PRCH has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the stronger earnings trend. Trailing diluted EPS is up 125% for NVDA versus PRCH down 54%.
PRCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +7.9% |
| Q3 2025 | $0.31 | +$0.99 |
| Q2 2025 | $0.53 | +$1.39 |
| Q1 2025 | -$0.12 | +$1.00 |
| Q4 2024 | -$0.33 | +$1.06 |
| Q3 2024 | -$0.68 | +$1.06 |
| Q2 2024 | -$0.86 | +$1.70 |
| Q1 2024 | -$1.12 | +$0.80 |
| Q4 2023 | -$1.39 | +$0.18 |
PRCH has returned to profit: it earned $0.31 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PRCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PRCH on profitability, with a higher operating margin.
PRCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $143.9M | +22% |
| Q2 2026 | $140.9M | +18% |
| Q1 2026 | $121.1M | +16% |
| Q4 2025 | $140.3M | +40% |
| Q3 2025 | $118.1M | +6.2% |
| Q2 2025 | $119.3M | +7.6% |
| Q1 2025 | $104.7M | -9.3% |
| Q4 2024 | $100.4M | -12% |
PRCH's revenue has grown year over year for six quarters in a row: $144M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -1.3 points |
| Q2 2026 | -2.9% | -7.2 points |
| Q1 2026 | 9.8% | +11 points |
| Q4 2025 | 12% | -13 points |
| Q3 2025 | 14% | +16 points |
| Q2 2025 | 4.2% | +52 points |
| Q1 2025 | -1.2% | +29 points |
| Q4 2024 | 25% | +19 points |
PRCH's operating margin was 13% last quarter, down 1.3 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
PRCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $59.2M | +45% |
| Q2 2026 | $40.9M | +16% |
| Q1 2026 | $12.8M | +$24.1M |
| Q4 2025 | $1.1M | +$27.9M |
| Q3 2025 | $40.7M | +234% |
| Q2 2025 | $35.4M | +$61.4M |
| Q1 2025 | -$11.2M | -233% |
| Q4 2024 | -$26.8M | +$14.3M |
PRCH generated $114M in free cash flow over the past year, about three times what it generated the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PRCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.6% | +5.6M shares |
| 1 year | -4.1% | -5.4M shares |
| 3 years | +32% | +30.6M shares |
| 5 years | +33% | +31.1M shares |
PRCH has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $2.5M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over PRCH on leverage, with a lower net debt burden relative to earnings.
PRCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 5.7x | High |
| Q3 2025 | 4.5x | High |
| Q2 2025 | 6.3x | High |
PRCH's net debt is about 2.5 years of its operating earnings (EBITDA), down from 4.5 years a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PRCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.1 | Overbought |
| Stochastic | 82.5 | Overbought |
PRCH's weekly RSI is 71 (overbought) and its Stochastic is 83 (overbought).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PRCH PE vs Technology Sector
| Metric | PRCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
PRCH has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
PRCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.5 | 15% above |
| 20 week MA | $16.8 | 27% above |
| 50 week MA | $12.1 | 76% above |
| 100 week MA | $11.2 | 91% above |
| 200 week MA | $6.59 | 223% above |
PRCH has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
PRCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.0 | $15.0 | +50% |
| 2021 | $15.0 | $17.8 | +19% |
| 2022 | $17.8 | $1.70 | -90% |
| 2023 | $1.70 | $3.08 | +81% |
| 2024 | $3.08 | $5.44 | +77% |
| 2025 | $5.44 | $8.93 | +64% |
| 2026 YTD | $8.93 | $21.3 | +139% |
PRCH has the edge over NVDA on returns for 2026, with the stronger performance.